Table 1.
Participant Characteristics
| Group M (SD) | ||
|---|---|---|
| Control | SZ | |
| (n=10) | (n=10) | |
| Gender (% female) | 50% | 40% |
| Age (years)a | 43.2 (10.18) | 45.2 (6.05) |
| Years of Educationb | 15.4 (2.12) | 12.7 (1.42) |
| WASI Full-scale IQc | 104.78 (12.65) | 95.7 (8.65) |
| WASI Verbal IQd | 104.44 (9.9) | 94 (10.38) |
| WASI Performance IQe | 103.89 (15.61) | 98.1 (7.80) |
| SANSf | - | 33.5 (15.46) |
| SAPSg | - | 22.1 (17.23) |
| Duration of Condition (years) | - | 24.78 (9.72) |
a
No between-group difference in age, t(18)=−0.53, p=.60.
b
Participants in the control group had significantly more years of education than participants in the SZ group, t(18)=3.35, p=.004.
c
WASI Wechsler Abbreviated Scale of Intelligence; No between-group difference on full-scale IQ, t(17)=1.84, p=.08.
d
Verbal IQ component of WASI; Participants in the control group had significantly higher verbal IQ than participants in the SZ group, t(17)=2.24, p=.039.
e
Performance IQ component of WASI; No between-group difference on performance IQ, t(17)=1.04, p=.313.
f
SANS Scale for the Assessment of Negative Symptoms
g
SAPS Scale for the Assessment of Positive Symptoms